510(k) Report

510(k) · Cleared

Recalled · Class II · 2019

Flexitron

K070574510(k) AbbreviatedCleared Apr 13, 200744-day reviewClass II21 CFR 892.5700Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Isodose Control B.V. · JAQ System, Applicator, Radionuclide, Remote-Controlled

Cleared on Apr 13, 2007 as substantially equivalent to K953946 (Nucletron-Oldelft Corp., 1996) and 1 other predicate after a 44-day review. Its family tree reaches back 3 generations to 1991. It has been recalled once.

Decided
Apr 13, 2007
Review
44 days
Class
Class II
Product code
JAQ
Recalls
1
Predicates
2

Its longest line of descent runs back 3 generations to K912555 (1991). 6 ancestors in all, the oldest K864210 (1986). No later device cites it as a predicate yet.

  1. Root · 3 generations backK912555 Gammamed 12IT High Dose Rate Remote AfterloaderRts Technology, Inc. · 1991 · Recalled
  2. 2 generations backK983436 Gammamed Plus High Dose Rate Remote Afterloading SystemGammamed USA · 1998 · Recalled
  3. 1 generation backK031524 Gammamed Plus 3/24 HDR Remote AfterloaderVarian Medical Systems, Inc. · 2003 · Recalled
  4. This deviceK070574 FlexitronIsodose Control B.V. · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K912555Gammamed 12IT High Dose Rate Remote AfterloaderRts Technology, Inc.19912
−2K983436Gammamed Plus High Dose Rate Remote Afterloading SystemGammamed USA199817
−1K031524Gammamed Plus 3/24 HDR Remote AfterloaderVarian Medical Systems, Inc.20031
0 (this device)K070574FlexitronIsodose Control B.V.2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198610
199310
199610
FIG. 1 — Lineage of K070574, 1991–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAQ device

  1. #1 K241853 Titanium Fletcher-Style Applicator Set Defined…score 14.9 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K953946Microselectron-HDR Version 2
Summary page 1
…Manufacturer 510(k # ImicroSelectron-HDR Version 2 INucletron byv K953946 GammaMed Plus 3/24 High Dose Rate (HDR) Varian Medical Systems Inc K031524 Remote Afterloader company Con…
Nucletron-Oldelft Corp.1996—
*K031524Gammamed Plus 3/24 HDR Remote Afterloader
Summary page 1
…ctron-HDR Version 2 INucletron byv K953946 GammaMed Plus 3/24 High Dose Rate (HDR) Varian Medical Systems Inc K031524 Remote Afterloader company Confidential Section 5: 510(k) Summary…
Varian Medical Systems, Inc.20031

Also cleared against K953946: 27 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Nov 18, 2019Class IIZ-0772-2020Process controlA component failure may lead to treatment interruption or incorrect source positioning.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 4 companies; a new generation was cleared every 5.1 years on median.
  • 3 of the 6 ancestors have a recall of any class.
  • 27 other devices also cite its predicate K953946.

How does its category compare?

All JAQ devices

JAQ System, Applicator, Radionuclide, Remote-Controlled: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · JAQ

6in 2025

2007: 112008: 102009: 102010: 22011: 22012: 72013: 62014: 72015: 112016: 62017: 72018: 72019: 22020: 42022: 12023: 22024: 102025: 62026 (partial year): 2
2007high 11 (2007) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAQ

91in 2025

2007: 48 days median2008: 34 days median2009: 27 days median2012: 89 days median2013: 100 days median2014: 116 days median2015: 183 days median2016: 154 days median2017: 229 days median2018: 252 days median2020: 62 days median2024: 126 days median2025: 91 days median
2007high 252 (2018) · low 27 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAQ

1in 2019

2008: 52009: 12010: 22011: 132012: 52013: 12019: 12026 (partial year): 3
2007high 13 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAQ

3in 2025

2007: 132008: 322009: 352010: 362011: 422012: 342013: 432014: 182015: 72016: 32017: 52018: 22019: 82020: 82021: 52022: 52023: 32024: 12025: 3
2007high 43 (2013) · low 1 (2024)2025

MAUDE reports naming product code JAQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071148013
20081034532
20091027135
20102—236
20112—1342
2012789534
20136100143
20147116018
20151118307
2016615403
2017722905
2018725202
20192—18
202046208
20210—05
20221—05
20232—03
20241012601
202569103
20262—3—

What is it indicated for?

The Flexitron Remotely Controlled Brachytherapy Afterloading System is intended to enable an operator to apply by remote control a radionuclide source (Flexisource) into the body or to the surface of the body for radiation therapy.

Flexitron is intended to be used in combination with applicators which makes it suitable for intracavitary, interstitial, intralumenary, bronchial, endovascular, intra-operative and surface brachytherapy treatment.

Flexitron is intended to be used for medical procedures on patients to be prescribed and performed by a suitably trained and authorized medical professional.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K070574: Flexitron.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K070574

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026